Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy

Journal of the American College of Cardiology

Volumn 44, Issue 3, 2004, Pages 602-610

  Van Driest, Sara L ^a   Jaeger, Michele A ^a   Ommen, Steve R ^a   Will, Melissa L ^a   Gersh, Bernard J ^a   Tajik, A Jamil ^a   Ackerman, Michael J ^a,b  

^a Mayo Clinic   (United States)

^b MAYO CLINIC   (United States)

Author keywords

beta myosin heavy chain gene; denaturing high performance liquid chromatography; DHPLC; HCM; hypertrophic cardiomyopathy; ICD; implantable cardioverter defibrillator; left ventricular wall thickness; LVWT; MYH7; PCR; polymerase chain reaction; SCD

Indexed keywords

DNA; MYOSIN HEAVY CHAIN; MYOSIN HEAVY CHAIN BETA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; DNA DETERMINATION; DNA SEQUENCE; EXON; FAMILY HISTORY; FEMALE; GENE; GENE EXPRESSION; GENE FUNCTION; GENE MUTATION; GENETIC ANALYSIS; GENETIC CODE; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; MUSCLE RESECTION; MUTATIONAL ANALYSIS; MYH7 GENE; PHENOTYPE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; SUDDEN DEATH;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; CARDIOMYOPATHY, HYPERTROPHIC; CHILD; CHILD, PRESCHOOL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COHORT STUDIES; DNA MUTATIONAL ANALYSIS; EXONS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; INFANT; INFANT, NEWBORN; MALE; MEDICAL RECORDS; MIDDLE AGED; MUTATION; PHENOTYPE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RISK ASSESSMENT; VENTRICULAR MYOSINS;

EID: 4043081356     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2004.04.039     Document Type: Article

References (30)

1. Maron B.J., Gardin J.M., Flack J.M., Gidding S.S., Kurosaki T.T., Bild D.E. Prevalence of hypertrophic cardiomyopathy in a general population of young adults Echocardiographic analysis of 4111 subjects in the coronary artery risk development in (young) adults (cardia) study. Circulation. 92:1995;785-789
2. Maron B.J. Hypertrophic cardiomyopathy A systematic review. JAMA. 287:2002;1308-1320
3. Maron B.J., Carney K.P., Lever H.M., et al. Relationship of race to sudden cardiac death in competitive athletes with hypertrophic cardiomyopathy. J Am Coll Cardiol. 41:2003;974-980
4. Arad M., Seidman J.G., Seidman C.E. Phenotypic diversity in hypertrophic cardiomyopathy. Hum Mol Genet. 11:2002;2499-2506
5. Maron B.J., Bonow R.O., Cannon R.O., Leon M.B., Epstein S.E. Hypertrophic cardiomyopathy Interrelations of clinical manifestations, pathophysiology, and therapy. N Engl J Med. 316:1987;780-789
6. Spirito P., Seidman C.E., McKenna W.J., Maron B.J. The management of hypertrophic cardiomyopathy. N Engl J Med. 336:1997;775-785
7. Seidman J.G., Seidman C. The genetic basis for cardiomyopathy From mutation identification to mechanistic paradigms. Cell. 104:2001;557-567
8. Burch M., Blair E. The inheritance of hypertrophic cardiomyopathy. Pediatr Cardiol. 20:1999;313-316
9. Roberts R., Sigwart U. New concepts in hypertrophic cardiomyopathies, part I. Circulation. 104:2001;2113-2116
10. Seidman C.E., Seidman J.G. Molecular genetic studies of familial hypertrophic cardiomyopathy. Basic Res Cardiol. 93:1998;13-16
11. The FHC Mutation Database, ANGIS 2001. Available at: http://morgan.angis. su.oz.au/Databases/Heart/dbsearch.html. Accessed March 16, 2004.
12. Marian A.J., Roberts R. Molecular genetic basis of hypertrophic cardiomyopathy Genetic markers for sudden cardiac death. J Cardiovasc Electrophysiol. 9:1998;88-99
13. Fananapazir L., Dalakas M.C., Cyran F., Cohn G., Epstein N.D. Missense mutations in the beta-myosin heavy-chain gene cause central core disease in hypertrophic cardiomyopathy. Proc Natl Acad Sci USA. 90:1993;3993-3997
14. Watkins H., Rosenzweig A., Hwang D.S., et al. Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. N Engl J Med. 326:1992;1108-1114
15. Richard P., Charron P., Carrier L., et al. Hypertrophic cardiomyopathy Distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation. 107:2003;2227-2232
16. Antonarakis S.E. Nomenclature Working Group. Recommendations for a nomenclature system for human gene mutations. Hum Mutat. 11:1998;1-3
17. Van Driest S.V., Ellsworth E.G., Ommen S.R., Tajik A.J., Gersh B.J., Ackerman M.J. Prevalence and spectrum of thin filament mutations in an outpatient referral population with hypertrophic cardiomyopathy. Circulation. 108:2003;445-451
18. Towbin J.A. Molecular genetic basis of sudden cardiac death. Cardiovasc Pathol. 10:2001;283-295
19. Hwang T., Lee W., Kimura A., et al. Early expression of a malignant phenotype of familial hypertrophic cardiomyopathy associated with a Gly716Arg myosin heavy chain mutation in a Korean family. Am J Cardiol. 82:1998;1509-1513
20. Ackerman M.J., Van Driest S.V., Ommen S.R., et al. Prevalence and age-dependence of malignant mutations in the beta-myosin heavy chain and troponin T gene in hypertrophic cardiomyopathy A comprehensive outpatient perspective. J Am Coll Cardiol. 39:2002;2042-2048
21. Consevage M.W., Salada G.C., Baylen B.G., Ladda R.L., Rogan P.K. A new missense mutation, Arg719Gln, in the beta-cardiac heavy chain myosin gene of patients with familial hypertrophic cardiomyopathy. Hum Mol Genet. 3:1994;1025-1026
22. Van Driest S.V., Ackerman M.J., Ommen S.R., et al. Prevalence and severity of 'benign' mutations in the beta myosin heavy chain, cardiac troponin-T, and alpha tropomyosin genes in hypertrophic cardiomyopathy. Circulation. 106:2002;3085-3090
23. Woo A., Rakowski H., Liew J.C., et al. Mutations of the beta myosin heavy chain gene in hypertrophic cardiomyopathy Critical functional sites determine prognosis. Heart. 89:2003;1179-1185
24. Rayment I., Holden H.M., Sellers J.R., Fananapazir L., Epstien N.D. Structural interpretation of the mutations in the beta-cardiac myosin that have been implicated in familial hypertrophic cardiomyopathy. Proc Natl Acad Sci USA. 92:1995;3864-3868
25. Jaaskelainen P., Soranta M., Miettinen R., et al. The cardiac beta-myosin heavy chain gene is not the predominant gene for hypertrophic cardiomyopathy in the Finnish population. J Am Coll Cardiol. 32:1998;1709-1716
26. Xiao W., Oefner P. Denaturing high-performance liquid chromatography A review. Hum Mutat. 17:2001;439-474
27. Schollen E., Martens K., Geuzens E., Matthijs G. DHPLC analysis as a platform for molecular diagnosis of congenital disorders of glycosylation (CDG). Eur J Hum Genet. 10:2002;643-648
28. Young J., Barker M., Fraser L., et al. Mutation searching in colorectal cancer studies Experience with a denaturing high-pressure liquid chromatography system for exon-by-exon scanning of tumour suppressor genes. Pathology. 34:2002;529-533
29. Mogensen J., Bahl A., Kubo T., Elanko N., Taylor R., McKenna W.J. Comparison of fluorescent SSCP and denaturing HPLC analysis with direct sequencing for mutation screening in hypertrophic cardiomyopathy. J Med Genet. 40:2003;1-5
30. Blair E., Redwood C., de Jesus Oliveira M., et al. Mutations of the light meromyosin domain of the beta-myosin heavy chain rod in hypertrophic cardiomyopathy. Circ Res. 90:2002;263-269